Skip to content

Latest

VIVUS gets FDA OK for obesity drug

VIVUS Inc. has been cleared by the Food and Drug Administration to market Qsymia, a weight-loss pill aimed at adults struggling with obesity and related health conditions.

Winn-Dixie rolls out prescription discount program

Winn-Dixie has launched a prescription savings program offering deep discounts on more than 400 generic drugs and various levels of savings on brand-name medications and other generics. The Rx discount program runs through the Winn-Dixie Reward Card.

NACDS, NCPA brief Senate caucus on Rx abuse

The National Association of Chain Drug Stores and the National Community Pharmacists Association provided comment to a Senate caucus on the pharmacy sector’s engagement in the prevention of prescription drug abuse.

Duane Reade promotes electric vehicle use

To help reduce vehicle air pollution, Duane Reade is asking to New Yorkers which of its drug stores should be served solely by electric trucks. The Manhattan-based drug chain, part of Walgreen Co.

Lannett appoints new chairman

Jeffrey Farber, vice chairman at Lannett Co., has been named chairman, succeeding Ronald West. The generic drug maker said Monday that Farber takes over the chairman’s post effective immediately.

RxAlly names general counsel

Tom O’Grady has joined pharmacy alliance RxAlly as general counsel and executive vice president of corporate development. RxAlly said Monday that O’Grady, previously with the law firm McGuireWoods LLP, brings more than 30 years of corporate and transactional law experience to the company.

Par Pharma to be sold to TPG

Par Pharmaceutical Cos. has agreed to be acquired by private equity firm TPG in a deal valued at $1.9 billion. The generic drug and specialty pharmaceutical company said Monday that under the agreement, Par can solicit proposals from other parties until Aug. 24, and its board plans to do so. If

GSK to buy Human Genome Sciences

GlaxoSmithKline plans to acquire Human Genome Sciences (HGS) in a cash deal of about $3 billion. GSK said Monday that the purchase of HGS will give the company full ownership of the medications Benlysta (lupus), albiglutide (type 2 diabetes) and darapladib (coronary heart disease).

Apothecary Shops to become Avella Specialty Pharmacy

Next month, The Apothecary Shops is changing its name and brand to Avella Specialty Pharmacy. The specialty pharmacy chain said Monday that it will officially switch to the Avella banner at all locations and in all business operations on Aug. 1.

Cardinal Health spotlights pharmacy best practices

At its Retail Business Conference (RBC) here, Cardinal Health Inc. introduced "Independent Pharmacy Best Practices 2012: Ideas as Original As You Are," a special publication that showcases 16 community pharmacy programs that improve patient care and drive business results.